Jing zhang apple free#

(2005) Residue 33 of human equilibrative nucleoside transporter 2 is a functionally important component of both the dipyridamole and nucleoside binding sites. Visser F, Zhang J, Roborn RT, Baldwin SA, Young JD, Cass CE.(* These authors contributed equally to this work.) (2005) Identification and functional characterization of variants in human concentrative nucleoside transporter 3, hCNT3 (SLC28A3), arising from single nucleotide polymorphisms in coding regions of the hCNT3 gene.

Damaraju* S, Zhang* J, Visser F, Tackaberry T, Dufour J, Baldwin SA, Young JD, Cass CE.(2005) Uridine binding and transportability determinants of human concentrative nucleoside transporters. Zhang J, Smith KM, Tackaberry T, Visser F, Robins MJ, Nielsen LP, Nowak I, Baldwin SA, Young JD, Cass CE.(2006) Uptake of 4′-thio-ß-D-arabinofuranosylcytosine and ß-D-arabinosylcytosine by human nucleoside transporters. Clarke ML, Damaraju VL, Zhang J, Mowles D, Tackaberry T, Lang T, Smith KM, Young JD, Tomkinson B, Cass CE.(2006) Cysteine accessibility analysis of transmembrane domain 11, 12 and 13 of human concentrative nucleoside transporter 3. Zhang J, Tackaberry T, Barron G, Baldwin SA, Young JD, Cass CE.(2006) Characterization of the transport mechanism and permeant binding profile of the uridine permease Fui1p of saccharomyces cerevisiae.

Zhang J, Smith KM, Tackaberry T, Sun X, Carpenter P, Slugoski MD, Robins MJ, Nielsen LP, Nowak I, Baldwin SA, Young JD, Cass CE.

(2006) Studies of nucleoside transporters using autofluorescent nucleoside analogs.

Zhang J, Sun X, Smith KM, Carpenter P, Barron G, Robins M, Baldwin SA,Young JD, Cass CE.

(2008) Mutation of Trp29 of human equilibrative nucleoside transporter 1 alters affinity for coronary vasodilator drugs and nucleoside selectivity.

Paproski RJ, Visser F, Zhang J, Tackaberry T, Damaraju V, Baldwin SA, Young JD, Cass CE.

(2008) A conformationally mobile cysteine residue (Cys-561) modulates Na+ and H+ activation of human CNT3.

Slugoski MD, Smith KM, Mulinta R, Ng AM, Yao SY, Morrison EL, Lee QO, Zhang J, Karpinski E, Cass CE, Baldwin SA, Young JD.

(2007) The role of nucleoside transporters in cancer chemotherapy with nucleoside drugs.

Zhang J, Visser F, King KM, Baldwin SA, Young JD, Cass CE.

(2012) Patient satisfaction and health-related quality of life following autologous tissue breast reconstruction: A prospective analysis of early postoperative outcomes.

Zhong T, McCarthy C, Min S, Zhang J, Beber B, Pusic A, Hofer SOP.

(2013) Transport of A1 adenosine receptor agonist tecadenoson by human and mouse nucleoside transporters: evidence for blood-brain barrier transport by murine equilibrative nucleoside transporter 1 mENT1.

Lepist EI, Damaraju VL, Zhang J, Gati WP, Yao SY, Smith KM, Karpinski E, Young JD, Leung KH, Cass CE.

Jing zhang apple free#

(2014) Using propensity score analysis to compare major complications between DIEP and free muscle-sparing TRAM flap breast reconstructions. Zhong T, Novak CB, Bagher S, Maass SW, Zhang J, Arad U, O’Neill AC, Metcalfe KA, Hofer SO.